Semaglutide through VSDH's branded pharmacy network
Compounded semaglutide is typically dispensed in multi-dose vials, and a titration program draws escalating doses from those vials as the patient steps up. VSDH markets GLP-1 weight-management therapies through a managed branded pharmacy spanning 503A and 503B suppliers — VSDH is the platform and fulfillment orchestration layer, not the compounding pharmacy itself. Concentrations, vial sizes, and which supplier fulfills each SKU depend on your partner agreement, so confirm the formulary in a live demo rather than assuming a fixed catalog on vsdigitalhealth.com.
This page is about ordering workflow, not clinical dosing. The platform's job is to make the right vial reach the patient with a correct SIG and licensure handled — not to advise on titration schedules. What you should evaluate is whether VSDH surfaces per-vial economics and pre-pay validation for a high-volume GLP-1 clinic, or whether you are primarily buying a white-label consumer stack where batch refill-day checkout is secondary.